TRAVERE THERAPEUTICS, INC. (TVTX)

Import this data to Google Sheets with:

=jivedata("TVTX","financials")

Full statements spill as a table. For one cell: =jivedata("TVTX","Revenue") or =jivedata("TVTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

TRAVERE THERAPEUTICS, INC.

TVTX • CIK 0001438533

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$145,238	$233,175	$490,728	$591,330
Operating Income (Loss)	$-388,138	$-323,827	$-62,824	$-40,458
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-376,110	$-320,510	$-49,273	$-67,074
Income Tax Expense (Benefit)	$223	$120	$988	$605
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	$-376,333	$-320,630	$-50,261	$-67,679
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	$264,934	$-915	$24,715	$24,215
Net Income (Loss) Attributable to Parent	$-111,399	$-321,545	$-25,546	$-43,464
Cost of Goods and Services Sold	$11,450	$7,744	$10,339	$8,261
Research and Development Expense (Excluding Acquired in Process Cost)	$244,990	$217,496	$206,011	$227,137
Selling, General and Administrative Expense	$265,542	$264,119	$337,202	$364,513
Restructuring Charges	$11,394	$2,438	$0	$0
Costs and Expenses	$533,376	$557,002	$553,552	$631,788
Investment Income, Interest	$21,768	$17,817	$12,721	$11,577
InterestExpenseNonoperating	—	$11,182	$10,748	$9,480
Other Nonoperating Income (Expense)	$1,594	$-3,318	$11,578	$11,295
Nonoperating Income (Expense)	$12,028	$3,317	$13,551	$-26,616
Weighted Average Number of Shares Outstanding, Basic	74,267,418	78,888,861	89,211,813	93,237,973
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent	$374	$-328	$-219	$-219
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	$-1,871	$1,422	$-945	$390
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent	$3,696	$-374	$-383	$-914
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-109,948	$-320,169	$-26,655	$-43,769

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$58,176	$58,535	$93,035	$117,735
Debt Securities, Available-for-sale	$508,675	$312,166	$229,761	$371,442
Inventory, Noncurrent	$31,494	$35,656	$30,280	$32,214
Accounts Receivable, after Allowance for Credit Loss, Current	$21,179	$27,116	$80,134	$80,636
Property, Plant and Equipment, Net	$7,479	$5,336	$4,022	$3,231
Inventory, Gross	—	—	$5,875	$7,835
Operating Lease, Right-of-Use Asset	$18,061	$14,295	$10,576	$8,745
Prepaid Expense and Other Assets, Current	$19,335	$12,685	$28,760	$37,493
Intangible Assets, Net (Excluding Goodwill)	$104,443	$103,974	$113,868	$131,518
Assets, Current	$616,775	$416,702	$437,565	$615,141
Other Assets, Noncurrent	$10,661	$18,162	$8,880	$8,511
Assets	$788,913	$594,125	$605,191	$799,360
Convertible Debt, Noncurrent	$377,263	$310,310	$311,724	$311,724
Operating Lease, Liability, Noncurrent	$22,612	$17,191	$11,134	$7,961
Other Liabilities, Noncurrent	$8,485	$6,796	$7,601	$12,071
Liabilities	$588,103	$535,048	$490,363	$774,838
Accounts Payable, Current	$41,675	$23,534	$24,800	$7,495
Accrued Liabilities, Current	$118,991	$86,028	$126,035	$136,267
Convertible Debt, Current	—	$68,678	$0	$0
Operating Lease, Liability, Current	$4,909	$5,405	$5,875	$6,163
Other Liabilities, Current	$5,237	$14,291	$3,194	$2,100
Liabilities, Current	$177,908	$200,751	$159,904	$152,025
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$7	$9	$9	$9
Additional Paid in Capital	$1,327,881	$1,506,315	$1,588,721	$1,570,242
Retained Earnings (Accumulated Deficit)	$-1,125,622	$-1,447,167	$-1,472,713	$-1,544,612
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-1,456	$-80	$-1,189	$-1,117
Stockholders' Equity Attributable to Parent	$200,810	$59,077	$114,828	$24,522
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	75,367,117	87,452,835	90,922,868	94,174,767

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-111,399	$-321,545	$-25,546	$-43,464
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	$264,934	$-915	$24,715	$24,215
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	$-376,333	$-320,630	$-50,261	$-67,679
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$1,981	$-913	$2,291	$-194
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	$-325,357	$-230,024	$37,784	$37,784
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-3,512	$359	$34,500	$42,581
Cash Provided by (Used in) Operating Activities, Discontinued Operations	$45,336	$-7,451	$0	$0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$58,176	$58,535	$93,035	$109,500
Net Cash Provided by (Used in) Operating Activities	$-280,021	$-237,475	$37,784	$92,700
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$334,575	$326,334	$323,595	$274,191
Payments to Acquire Marketable Securities	$443,942	$125,757	$237,142	$399,409
Payments to Acquire Intangible Assets	$41,591	$36,212	$58,157	$77,536
Payments for (Proceeds from) Other Investing Activities	$0	$40	$404	$467
Net Cash Provided by (Used in) Investing Activities, Continuing Operations	$-151,626	$99,325	$27,892	$27,892
Cash Provided by (Used in) Investing Activities, Discontinued Operations	$207,402	$0	$0	$0
Net Cash Provided by (Used in) Investing Activities	$55,776	$99,325	$27,892	$-202,986
Repayments of Convertible Debt	$0	$0	$68,904	$419,789
Proceeds from Issuance of Common Stock	$191,198	$134,738	$0	$0
Proceeds from Issuance of Warrants	$24,630	$0	$0	$0
Proceeds from Stock Options Exercised	$3,240	$4,452	$34,745	$62,609
Proceeds from Stock Plans	$3,166	$2,332	$2,792	$3,611
Net Cash Provided by (Used in) Financing Activities, Continuing Operations	$220,134	$139,422	$-33,467	$-33,467
Cash Provided by (Used in) Financing Activities, Discontinued Operations	$-1,382	$0	$0	$0
Net Cash Provided by (Used in) Financing Activities	$218,752	$139,422	$-33,467	$153,061
Depreciation, Depletion and Amortization	$38,530	$43,555	$60,743	$63,371
Share-based Payment Arrangement, Noncash Expense	$44,246	$36,913	$44,868	$60,661
Inventory Write-down	$3,039	$2,819	$684	$684
Amortization of Debt Issuance Costs and Discounts	$1,718	$1,725	$1,640	$1,640
Accretion (Amortization) of Discounts and Premiums, Investments	$7,456	$4,535	$4,436	$4,436
Other Noncash Income (Expense)	$3,626	$-7,944	$1,457	$3,378
Operating Lease, Payments	$6,315	$6,392	$6,578	$6,578
Interest Paid, Excluding Capitalized Interest, Operating Activities	$8,838	$8,838	$8,838	$8,838
Increase (Decrease) in Accounts Receivable	$11,264	$6,001	$27,822	$16,919
Increase (Decrease) in Inventories	$39,420	$3,771	$-5,016	$2,079
Increase (Decrease) in Income Taxes Receivable	$35	$41	$-849	$-849
Increase (Decrease) in Prepaid Expense and Other Assets	$4,657	$3,164	$7,658	$10,338
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$24,763	$-17,563	$-85	$-12,073
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$22,321	$-31,061	$28,840	$46,234
Increase (Decrease) in Contract with Customer, Liability	$-15,779	$-6,116	$-2,815	$0
Increase (Decrease) in Other Operating Liabilities	$-418	$5,646	$-9,700	$-6,338

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("TVTX","financials")

Full statements spill as a table. For one cell: =jivedata("TVTX","Revenue") or =jivedata("TVTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.